U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07189117) titled 'Cancer and Immune Cell Metabolism in Patients With Hematological Malignancies' on Sept. 05.
Brief Summary: This study investigates how metabolism in cancer and immune cells shapes the bone marrow environment, influences therapy resistance, and affects outcomes in hematological malignancies.
Study Start Date: Dec., 2025
Study Type: OBSERVATIONAL
Condition:
Hematologic Malignancy
Recruitment Status: NOT_YET_RECRUITING
Sponsor: University Hospital, Basel, Switzerland
Published by HT Digital Content Services with permission from Health Daily Digest....